Details
| Stereochemistry | MIXED |
| Molecular Formula | C15H19F3N2S |
| Molecular Weight | 316.385 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1CCCC(C)N1C(=S)NC2=CC=CC(=C2)C(F)(F)F
InChI
InChIKey=YTNJAWMNFLIDLW-UHFFFAOYSA-N
InChI=1S/C15H19F3N2S/c1-10-5-3-6-11(2)20(10)14(21)19-13-8-4-7-12(9-13)15(16,17)18/h4,7-11H,3,5-6H2,1-2H3,(H,19,21)
Ticarbodine is as effective broad-spectrum
canine anthelmintic. Ticarbodine is effective for the ascarids, hookworms, and tapeworms but not the whipworm of dogs. The drug is used in dogs for the removal of roundworms (Toxocara canis), hookworms (Ancylostoma caninum and Uncinaria stenocephala), and tapeworms (Dipylidium caninum and Taenia
pisiformis).
Originator
Sources: http://www.drugfuture.com/chemdata/ticarbodine.html | https://www.fda.gov/OHRMS/DOCKETS/98fr/cv00141.pdf
Curator's Comment: # Elanco Animal Health, A Div. of Eli Lilly & Co.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Toxocara canis |
|||
Target ID: CHEMBL612340 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Ticarbodine Approved UseThe drug is
used in dogs for the removal of
roundworms (Toxocara canis),
hookworms (Ancylostoma caninum and
Uncinaria stenocephala), and tapeworms
(Dipylidium caninum and Taenia
pisiformis). |
PubMed
| Title | Date | PubMed |
|---|---|---|
| In vitro activity of various anthelmintic compounds against Haemonchus contortus larvae. | 1983-11 |
|
| Critical and clinical evaluation of ticarbodine as a canine anthelmintic. | 1972-05 |
|
| Efficacy of single oral doses of ticarbodine against nematodes and cestodes of dogs. | 1972-04 |
Patents
Sample Use Guides
Dogs: Dosage is administered at 45 milligrams
of the drug per pound of body
weight in a single dose. Dosage may be
repeated in 21 days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6686387
Ticarbodine was active against Haemonchus contortus at a concentration of 100 ug/ cm(-3) or less.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C003469
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
100000082186
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104761
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
3023
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
DTXSID40865615
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
SUB11026MIG
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
m966
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | Merck Index | ||
|
31932-09-9
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
C75234
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
J4CLF34O60
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY | |||
|
3034015
Created by
admin on Wed Apr 02 06:54:11 GMT 2025 , Edited by admin on Wed Apr 02 06:54:11 GMT 2025
|
PRIMARY |
ACTIVE MOIETY